Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
Targeted Oncology
5d
A Closer Look at T-DXd in HER2-Positive Breast Cancer
Sarah Sammons, MD, medical oncologist, clinical investigator in the Breast Oncology Center, associate director of the ...
Medscape
5d
Trastuzumab Deruxtecan Shows Promise in HER2+ BC with Brain Metastases
Patients with HER2-positive advanced or metastatic breast cancer received trastuzumab deruxtecan every 3 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Released after guilty plea
Feds subpoena Schaeffer
Russia threatens retaliation
Pandas leaving for China
SC 1st execution in 13 years
Jurors begin deliberations
Sesame Place suit verdict
Drug price challenge revived
WI high court to decide
Boeing defense chief exits
TN abortion law blocked
FDA approves flu vaccine
Sues pharmacy middlemen
144K+ Mavericks recalled
House repeals emission rules
Hand count approved in GA
Top Hezbollah leader killed?
Rallies in North Carolina
Baby powder recalled
Bill to boost security OK'd
$230 million crypto theft
Hiker injured in bear attack
1st rabies outbreak in seals
Stein's ballot bid rejected
MS sheriff's office probe
Recalling 449K+ vehicles
In-person voting begins
Disney to stop using Slack
Beirut strike death toll
$3B for battery projects
Feedback